Vault-13

TCG Crossover Management, LLC

PALO ALTO, CA · CIK 1839948 · 13F filing filed 2023-08-14

No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.

$609.8m reported value +18.9% vs Q1 2023
22positions
80.7%in top 10
2 new 4 added 1 reduced 2 sold out vs Q1 2023

Holdings, Q2 2023

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 IVERIC BIO INC COM OPHT OPHT 2,448,829 $96.3m15.80% 15.80% ReducedShares held: Q3 2022 3.9m, Q4 2022 5.1m, Q1 2023 5.1m, Q2 2023 2.4m -2.7m -2,692,289 -52.4%
2 GERON CORP COM GERN GERN 23,589,779 $75.7m12.42% 12.42% AddedShares held: Q3 2022 12.1m, Q4 2022 15.2m, Q1 2023 17.8m, Q2 2023 23.6m +5.8m +5,824,566 32.8%
3 COGENT BIOSCIENCES INC COM COGT COGT 5,631,042 $66.7m10.93% 10.93% AddedShares held: Q3 2022 3.5m, Q4 2022 3.6m, Q1 2023 3.6m, Q2 2023 5.6m +2.0m +2,000,000 55.1%
4 VECTIVBIO HLDG AG ORD SHS ORD SHS 3,113,600 $52.9m8.68% 8.68% UnchangedShares held: Q3 2022 0, Q4 2022 2.3m, Q1 2023 3.1m, Q2 2023 3.1m
5 AEROVATE THERAPEUTICS INC COM COM 2,201,274 $37.8m6.19% 6.19% AddedShares held: Q3 2022 959.6k, Q4 2022 1.1m, Q1 2023 1.1m, Q2 2023 2.2m +1.1m +1,120,000 103.6%
6 ICOSAVAX INC COM COM 3,703,704 $36.8m6.03% 6.03% NewShares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 3.7m
7 MADRIGAL PHARMACEUTICALS INC COM MDGL MDGL 149,917 $34.6m5.68% 5.68% UnchangedShares held: Q3 2022 30.0k, Q4 2022 288.1k, Q1 2023 149.9k, Q2 2023 149.9k
8 TYRA BIOSCIENCES INC COM TYRA TYRA 1,989,103 $33.9m5.56% 5.56% UnchangedShares held: Q3 2022 945.7k, Q4 2022 2.0m, Q1 2023 2.0m, Q2 2023 2.0m
9 KALVISTA PHARMACEUTICALS INC COM KALV KALV 3,395,495 $30.6m5.01% 5.01% UnchangedShares held: Q3 2022 0, Q4 2022 3.4m, Q1 2023 3.4m, Q2 2023 3.4m
10 VENTYX BIOSCIENCES INC COM VTYX VTYX 815,724 $26.8m4.39% 4.39% UnchangedShares held: Q3 2022 0, Q4 2022 787.2k, Q1 2023 815.7k, Q2 2023 815.7k
11 DYNE THERAPEUTICS INC COM DYN DYN 1,650,150 $18.6m3.04% 3.04% UnchangedShares held: Q3 2022 0, Q4 2022 0, Q1 2023 1.7m, Q2 2023 1.7m
12 KURA ONCOLOGY INC COM KURA KURA 1,423,642 $15.1m2.47% 2.47% UnchangedShares held: Q3 2022 1.3m, Q4 2022 1.4m, Q1 2023 1.4m, Q2 2023 1.4m
13 STRUCTURE THERAPEUTICS INC SPONSORED ADS GPCR GPCR 350,000 $14.5m2.39% 2.39% UnchangedShares held: Q3 2022 0, Q4 2022 0, Q1 2023 350.0k, Q2 2023 350.0k
14 IMMUNOVANT INC COM IMVT IMVT 654,853 $12.4m2.04% 2.04% UnchangedShares held: Q3 2022 0, Q4 2022 854.9k, Q1 2023 654.9k, Q2 2023 654.9k
15 SILENCE THERAPEUTICS PLC ADS SLN SLN 2,104,875 $11.6m1.90% 1.90% UnchangedShares held: Q3 2022 2.1m, Q4 2022 2.1m, Q1 2023 2.1m, Q2 2023 2.1m
16 AN2 THERAPEUTICS INC COM ANTX ANTX 1,289,320 $11.0m1.80% 1.80% NewShares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 1.3m
17 ENTRADA THERAPEUTICS INC COM TRDA TRDA 584,955 $8.9m1.45% 1.45% UnchangedShares held: Q3 2022 642.2k, Q4 2022 585.0k, Q1 2023 585.0k, Q2 2023 585.0k
18 MERUS N V COM MRUS MRUS 300,000 $7.9m1.30% 1.30% UnchangedShares held: Q3 2022 300.0k, Q4 2022 300.0k, Q1 2023 300.0k, Q2 2023 300.0k
19 CABALETTA BIO INC COM CABA CABA 486,795 $6.3m1.03% 1.03% UnchangedShares held: Q3 2022 0, Q4 2022 486.8k, Q1 2023 486.8k, Q2 2023 486.8k
20 ACLARIS THERAPEUTICS INC COM ACRS ACRS 529,839 $5.5m0.90% 0.90% UnchangedShares held: Q3 2022 1.1m, Q4 2022 1.1m, Q1 2023 529.8k, Q2 2023 529.8k
21 C4 THERAPEUTICS INC COM STK CCCC CCCC 1,276,574 $3.5m0.58% 0.58% AddedShares held: Q3 2022 0, Q4 2022 0, Q1 2023 1.2m, Q2 2023 1.3m +26.6k +26,574 2.1%
22 ALPINE IMMUNE SCIENCES INC COM NVLS NVLS 253,069 $2.6m0.43% 0.43% UnchangedShares held: Q3 2022 254.6k, Q4 2022 253.1k, Q1 2023 253.1k, Q2 2023 253.1k

Sold out since Q1 2023

SecurityTickerShares held beforeValue then
CYMABAY THERAPEUTICS INC CBAY CBAY 3,048,257 $26.6m3.0m shares
VIRIDIAN THERAPEUTICS INC VRDN VRDN 663,610 $16.9m663.6k shares